Pirepemat
Pirepemat ( ; developmental code name IRL752 or IRL-752) is a drug which is under development for the prevention of falls in people with Parkinson's disease and Parkinson's disease dementia.
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Pirepemat ( ; developmental code name IRL752 or IRL-752) is a drug which is under development for the prevention of falls in people with Parkinson's disease and Parkinson's disease dementia. It has been referred to as a "nootrope" (i.e., nootropic or cognitive enhancer). Pirepemat shows affinity for several neurotransmitter receptors and transporters.
These include the serotonin 5-HT 7 receptor (K i = 980 nM), the sigma σ 1 receptor (K i = 1,200 nM), the serotonin transporter (SERT) (K i = 2,500 nM), the α 2C -adrenergic receptor (K i = 3,800 nM), the α 2A -adrenergic receptor (K i = 6,500 nM), the serotonin 5-HT 2C receptor (K i = 6,600 nM), the serotonin 5-HT 2A receptor (K i = 8,100 nM), and the norepinephrine transporter (NET) (K i = 8,100 nM). It also shows affinity for the rat κ-opioid receptor (KOR) (K i = 6,500 nM) and has weak affinity for the α 1 -adrenergic receptor (K i = 21,000 nM).
The drug was an antagonist or inhibitor at all assessed targets (which included some but not all of the preceding sites). Pirepemat has been described as a "cortical enhancer" and has been reported to region-specifically increase norepinephrine, dopamine, and acetylcholine levels in the cerebral cortex.
Serotonin 5-HT 7 receptor antagonism and α 2 -adrenergic receptor antagonism were hypothesized to underlie these effects. In animals, pirepemat has been found to reverse hypoactivity induced by the dopamine depleting agent tetrabenazine whilst not increasing basal locomotor activity and not affecting or minimally influencing dextroamphetamine- and dizocilpine-induced locomotor hyperactivity.
See also
List of investigational Parkinson's disease drugs Motivation-enhancing drug Linepemat (possibly IRL757) Mesdopetam (IRL790)
External links
Pirepemat (IRL752) - IRLAB
Text derived from https://en.wikipedia.org/w/index.php?oldid=1370065333 under CC BY-SA 4.0; modifications have been made.